Injection site reactions Redness, mild swelling, itching, or small nodules at the injection site occurred in 5 to 15% of trial participants
We offer individualized treatment plans and ongoing monitoring to help you achieve your health goals safely and effectively
Reviewed by Emily Bigby, MD, Physician with Ivm Health Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice
Retatrutide is an investigational GLP-1/GIP/glucagon triple agonist with no MHRA, EMA, or FDA marketing authorisation
They may weigh less but feel physically flatter during workouts
Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans